These innovative treatments, Tirzepatide , represent a groundbreaking advancement in treating obesity and potentially associated conditions . They all are grouped as GLP-1 receptor agonists , meaning they to mimic the endogenous GLP-1 hormone , enhancing glucose release and reducing hunger . Although Tirzepatide each operates somewhat similarly, th